Insider · CIK 0001963544
Yu Xia
Files at SMMT (Summit Therapeutics Inc.). First filing Oct 23, 2025, latest Oct 23, 2025.
In brief
Yu Xia files SEC Form 4 as director at SMMT (Summit Therapeutics Inc.). Since Oct 23, 2025, Yu Xia has reported 1 open-market buy worth $10.0M and 0 open-market sells worth $0, the latest filed on Oct 23, 2025.
A track record needs three past buys with six months of prices behind them; Yu Xia has 0, so none is measured yet.
The newest scored trade: bought $10.0M of SMMT on Oct 21, 2025, filed Oct 23, 2025, scored 55 (moderate). In the last 12 months: 1 buy worth $10.0M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SMMT: Summit Therapeutics Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 55Moderate | Summit Therapeutics Inc. | $10.0M 533,617 shares | +2% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jan 2, 2026 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 6, 2026 |
| Oct 21, 2025 | SMMT Summit Therapeutics Inc. | POpen-market purchase Common Stockindirect: Akeso, Inc. | +533,617 | $18.74 | $10.0M | 32,057,147 | Oct 23, 2025 |
| Jan 2, 2024 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +35,000 | - | - | 35,000 | Jan 4, 2024 |
| Jan 2, 2024 | SMMT Summit Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +200,000 | - | - | 235,000 | Jan 4, 2024 |
Questions about Yu Xia
Answered from the filings on this page, as of the latest one.
Is Yu Xia buying or selling?
In the last 12 months Yu Xia reported 1 open-market buy worth $10.0M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $10.0M of SMMT on Oct 21, 2025. Grants, option exercises and tax withholding are not counted.
How did Yu Xia's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Yu Xia has 0.
Where does Yu Xia file Form 4?
Yu Xia has filed Form 4 at SMMT (Summit Therapeutics Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.